{"title":"105P Preliminary efficacy and safety results from ‘ReBirth’: A phase II study of risk-based bladder-sparing therapy for MIBC","authors":"Y. Shen, X. Lu, X. Ma, W. Liu, D. Ye","doi":"10.1016/j.iotech.2023.100577","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100577","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"109 46","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Rediti, A. J. Garcia, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, J. Oliveira, J-C. Goeminne, A. C. Marques, L. Greillier, X. Wang, D. Vincent, H.S. Hong, M. Cesaroni, C. Sotiriou, L. Buisseret
{"title":"179P Integrating multiplex immunofluorescence with gene expression data in the IMMUcan HER2-positive breast cancer cohort","authors":"M. Rediti, A. J. Garcia, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, J. Oliveira, J-C. Goeminne, A. C. Marques, L. Greillier, X. Wang, D. Vincent, H.S. Hong, M. Cesaroni, C. Sotiriou, L. Buisseret","doi":"10.1016/j.iotech.2023.100638","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100638","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"109 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T.U. Marron, O. Hapanowicz, N. Lucas, K. Wu, M. Buckstein, P. Tabrizian, B. Taouli, E. Kim, K. Garcia-Reyes, M.I. Fiel, S. Ward, N. Cohen, S. Hiotis, P. Thanigaimani, Y. Hao, I. Lowy, E.A. Miller, T.S. Uldrick, M. Schwartz, M. Merad
{"title":"LBA4 Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma","authors":"T.U. Marron, O. Hapanowicz, N. Lucas, K. Wu, M. Buckstein, P. Tabrizian, B. Taouli, E. Kim, K. Garcia-Reyes, M.I. Fiel, S. Ward, N. Cohen, S. Hiotis, P. Thanigaimani, Y. Hao, I. Lowy, E.A. Miller, T.S. Uldrick, M. Schwartz, M. Merad","doi":"10.1016/j.iotech.2023.100694","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100694","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 709","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138610470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. George, J. Larkin, K. Chepynoga, L.M. Garcia Fernandez, J. May, M. Dyer, M. Patel, M. Kurt
{"title":"103P Long-term survivorship rates among previously treated patients with advanced renal cell carcinoma (aRCC) achieving objective response with nivolumab","authors":"S. George, J. Larkin, K. Chepynoga, L.M. Garcia Fernandez, J. May, M. Dyer, M. Patel, M. Kurt","doi":"10.1016/j.iotech.2023.100575","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100575","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"115 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. J. Garcia, J. Krawczyk, M. Rediti, K. Gogolewski, M. Możejko, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, X. Wang, D. Vincent, J-C. Goeminne, J. Oliveira, H.S. Hong, M. Cesaroni, C. Sotiriou, E. Szczurek, L. Buisseret
{"title":"176P Multiplex-immunoflourescence spatial patterns to predict triple-negative breast cancer molecular subtypes in the IMMUcan study","authors":"A. J. Garcia, J. Krawczyk, M. Rediti, K. Gogolewski, M. Możejko, S. Tissot, S. Rusakiewicz, L. Despland, M. Morfouace, R. Liechti, F. Marzetta, X. Wang, D. Vincent, J-C. Goeminne, J. Oliveira, H.S. Hong, M. Cesaroni, C. Sotiriou, E. Szczurek, L. Buisseret","doi":"10.1016/j.iotech.2023.100635","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100635","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"102 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Reinmuth, M. Özgüroğlu, N. Leighl, D. Galetta, I. Hacibekiroglu, J. Roubec, M.A.N. Sendur, E. Bria, I. Cicin, C. Grohé, H. Harputluoglu, S. Kilickap, S. Novello, P. Opalka, F. Riccardi, R.K. Ruseva, S. Lang, M. Hodari, N. Donner, F. de Marinis
{"title":"LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (EP) for patients (pts) with extensive-stage SCLC (ES-SCLC): Primary results from the phase IIIb LUMINANCE study","authors":"N. Reinmuth, M. Özgüroğlu, N. Leighl, D. Galetta, I. Hacibekiroglu, J. Roubec, M.A.N. Sendur, E. Bria, I. Cicin, C. Grohé, H. Harputluoglu, S. Kilickap, S. Novello, P. Opalka, F. Riccardi, R.K. Ruseva, S. Lang, M. Hodari, N. Donner, F. de Marinis","doi":"10.1016/j.iotech.2023.100692","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100692","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138610260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T.U. Marron, A. Naing, C. Mantia, N. Pennell, H.R. Kim, L. Villaruz, A.B. El-Khoueiry, D.E. Gerber, A. Qin, T-Y. Kim, M. Altan, L. Gandhi, L. J. Appleman, S. Yoon, J. Hill, V. Reichert, R. Masia, L. Harshman, A. Patnaik, D. Morgensztern
{"title":"122P Casdozokitug (casdozo, SRF388), a first-in-class IL-27 targeting antibody, as monotherapy (monotx) or in combination with pembrolizumab (pembro) in treatment-refractory non-small cell lung cancer (NSCLC)","authors":"T.U. Marron, A. Naing, C. Mantia, N. Pennell, H.R. Kim, L. Villaruz, A.B. El-Khoueiry, D.E. Gerber, A. Qin, T-Y. Kim, M. Altan, L. Gandhi, L. J. Appleman, S. Yoon, J. Hill, V. Reichert, R. Masia, L. Harshman, A. Patnaik, D. Morgensztern","doi":"10.1016/j.iotech.2023.100594","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100594","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138612755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. M. Di Giacomo, M. Simonelli, F. Santangelo, G. Amato, E. Simonetti, J. Graham, M. Lahn, G. Di Conza, T. Hammett, R. Zorrilla, P. Kaur, T. Ziyang, T. Lakshmikanth, P. Brodin, M. Occhipinti, C. Carlo-Stella, A. Santoro, P. Spiliopoulou, T.R.J. Evans, M. Maio
{"title":"131P Safety and clinical efficacy of roginolisib (IOA-244): The first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ)","authors":"A. M. Di Giacomo, M. Simonelli, F. Santangelo, G. Amato, E. Simonetti, J. Graham, M. Lahn, G. Di Conza, T. Hammett, R. Zorrilla, P. Kaur, T. Ziyang, T. Lakshmikanth, P. Brodin, M. Occhipinti, C. Carlo-Stella, A. Santoro, P. Spiliopoulou, T.R.J. Evans, M. Maio","doi":"10.1016/j.iotech.2023.100603","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100603","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138613146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Wang, J. Gong, Y. Sun, S. Yang, M. Zhang, J. Cui, J. Lv, H. Su, J. Wang, J. Lu, J. Shan, J. Zhang, Y. Zhang, Y. Li, L. Gu, L. Li, X. Kang, L. Shen
{"title":"132P A phase I clinical trial of QLS31905 in advanced solid tumors","authors":"Y. Wang, J. Gong, Y. Sun, S. Yang, M. Zhang, J. Cui, J. Lv, H. Su, J. Wang, J. Lu, J. Shan, J. Zhang, Y. Zhang, Y. Li, L. Gu, L. Li, X. Kang, L. Shen","doi":"10.1016/j.iotech.2023.100604","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100604","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"144 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138615027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
